Paper · 30874331
The Sprouty/Spred family as tumor suppressors: Coming of age.
Kawazoe T and 1 other. Cancer Sci, 2019. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Sprouty/Spred family as tumor suppressors: Coming of age. Papers, record 30874331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30874331
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Membrane Proteins | Major topic |
| Neoplasms | Major topic |
| Disease Progression | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| MAP Kinase Signaling System | |
| Mitogen-Activated Protein Kinases | |
| Multigene Family | |
| ras Proteins |
Source PubMed
Grants33
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP18gm6210008 | Japan Agency for Medical Research and Development | PubMed | ||
| JP19gm6210008 | Japan Agency for Medical Research and Development | PubMed | ||
| JP15K21775 | Japan Society for the Promotion of Science | PubMed | ||
| "Kibou Projects" Startup Support for Young Researchers in Immunology | PubMed | |||
| Astellas Foundation for Research on Metabolic Disorders | PubMed | |||
| SENSHIN Medical Research Foundation | PubMed | |||
| Bristol-Myers Squibb | PubMed | |||
| SGH Foundation | PubMed | |||
| MSD Life Science Foundation | PubMed | |||
| Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care | PubMed |
1 to 10 of 33Source PubMed
See all 33 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,630,587 | Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25630587 | PubMed |
| 2 | 30,745,814 | A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia. | Int J Med Sci | 2019 | https://conductscience.org/library/papers/30745814 | PubMed |
| 3 | 16,489,004 | Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. | Cancer Res | 2006 | https://conductscience.org/library/papers/16489004 | PubMed |
| 4 | 27,621,461 | SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27621461 | PubMed |
| 5 | 25,973,316 | Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma. | Am J Cancer Res | 2015 | https://conductscience.org/library/papers/25973316 | PubMed |
| 6 | 28,223,824 | miR182 activates the Ras-MEK-ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/28223824 | PubMed |
| 7 | 25,633,921 | Correlation between microRNA‑21 and sprouty homolog 2 gene expression in multiple myeloma. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25633921 | PubMed |
| 8 | 24,932,220 | The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells. | J Ovarian Res | 2014 | https://conductscience.org/library/papers/24932220 | PubMed |
| 9 | 26,434,583 | Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition. | Oncogene | 2016 | https://conductscience.org/library/papers/26434583 | PubMed |
| 10 | 26,157,547 | Induction of Resistance to BRAF Inhibitor Is Associated with the Inability of Spry2 to Inhibit BRAF-V600E Activity in BRAF Mutant Cells. | Biomol Ther (Seoul) | 2015 | https://conductscience.org/library/papers/26157547 | PubMed |
1 to 10 of 87
See all 87 referencesCited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,929,490 | Intact lymph node homing and CD8+ T-cell priming abilities of Sprouty2-deficient dendritic cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929490 | PubMed |
| 41,516,252 | Sprouty in Tumors of the Nervous System. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516252 | PubMed |
| 41,155,983 | Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155983 | PubMed |
| 40,948,827 | Enhancing the sensitivity of lung adenocarcinoma to immune therapeutic agents through SPRED1. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/40948827 | PubMed |
| 40,915,975 | Poricoic Acid A attenuated TGF-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells through SPRY2/ERK signaling pathway. | Korean J Physiol Pharmacol | 2025 | https://conductscience.org/library/papers/40915975 | PubMed |
| 40,806,483 | The Lysine at Position 177 Is Essential to Limit the Inhibitory Capacities of Sprouty4 Protein in Normal and Cancer-Derived Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806483 | PubMed |
| 40,121,554 | BAMBI integrates biostatistical and artificial intelligence methods to improve RNA biomarker discovery. | Brief Bioinform | 2025 | https://conductscience.org/library/papers/40121554 | PubMed |
| 40,023,001 | SPRY1 regulates macrophage M1 polarization in skin aging and melanoma prognosis. | Transl Oncol | 2025 | https://conductscience.org/library/papers/40023001 | PubMed |
| 39,682,716 | Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells. | Cells | 2024 | https://conductscience.org/library/papers/39682716 | PubMed |
| 39,227,612 | SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation. | Sci Rep | 2024 | https://conductscience.org/library/papers/39227612 | PubMed |
1 to 10 of 39
See all 39 cited byGenes61
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADAM17 | 6,868 | PubTator's text mining | https://conductscience.org/library/genes/6868 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| AREG | 374 | PubTator's text mining | https://conductscience.org/library/genes/374 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CCAT1 | 100,507,056 | PubTator's text mining | https://conductscience.org/library/genes/100507056 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| DNMT1 | 1,786 | PubTator's text mining | https://conductscience.org/library/genes/1786 | NCBI Gene |
| DUSP5 | 1,847 | PubTator's text mining | https://conductscience.org/library/genes/1847 | NCBI Gene |
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
1 to 10 of 61
See all 61 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30874331
GET https://conductscience.org/api/papers/v1/30874331/grants?page=2